These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Inhibition of organic cation transporter 2 and 3 may be involved in the mechanism of the antidepressant-like action of berberine. Sun S; Wang K; Lei H; Li L; Tu M; Zeng S; Zhou H; Jiang H Prog Neuropsychopharmacol Biol Psychiatry; 2014 Mar; 49():1-6. PubMed ID: 24246570 [TBL] [Abstract][Full Text] [Related]
44. Association of changes in norepinephrine and serotonin transporter expression with the long-term behavioral effects of antidepressant drugs. Zhao Z; Zhang HT; Bootzin E; Millan MJ; O'Donnell JM Neuropsychopharmacology; 2009 May; 34(6):1467-81. PubMed ID: 18923402 [TBL] [Abstract][Full Text] [Related]
45. Estradiol reduced 5-HT reuptake by downregulating the gene expression of Plasma Membrane Monoamine Transporter (PMAT, Slc29a4) through estrogen receptor β and the MAPK/ERK signaling pathway. Gu Y; Zhang N; Zhu S; Lu S; Jiang H; Zhou H Eur J Pharmacol; 2022 Jun; 924():174939. PubMed ID: 35398393 [TBL] [Abstract][Full Text] [Related]
46. Altered response to the selective serotonin reuptake inhibitor escitalopram in mice heterozygous for the serotonin transporter: an electrophysiological and neurochemical study. Guiard BP; Mansari ME; Murphy DL; Blier P Int J Neuropsychopharmacol; 2012 Apr; 15(3):349-61. PubMed ID: 21439106 [TBL] [Abstract][Full Text] [Related]
47. Predominant role of plasma membrane monoamine transporters in monoamine transport in 1321N1, a human astrocytoma-derived cell line. Naganuma F; Yoshikawa T; Nakamura T; Iida T; Harada R; Mohsen AS; Miura Y; Yanai K J Neurochem; 2014 May; 129(4):591-601. PubMed ID: 24471494 [TBL] [Abstract][Full Text] [Related]
48. Adenosine transport by plasma membrane monoamine transporter: reinvestigation and comparison with organic cations. Zhou M; Duan H; Engel K; Xia L; Wang J Drug Metab Dispos; 2010 Oct; 38(10):1798-805. PubMed ID: 20592246 [TBL] [Abstract][Full Text] [Related]
49. Transporter-dependent uptake and metabolism of myocardial interstitial serotonin in the rat heart. Sonobe T; Akiyama T; Pearson JT J Physiol Sci; 2022 Oct; 72(1):27. PubMed ID: 36289481 [TBL] [Abstract][Full Text] [Related]
50. Serotonin transporter function, but not expression, is dependent on brain-derived neurotrophic factor (BDNF): in vivo studies in BDNF-deficient mice. Daws LC; Munn JL; Valdez MF; Frosto-Burke T; Hensler JG J Neurochem; 2007 May; 101(3):641-51. PubMed ID: 17254018 [TBL] [Abstract][Full Text] [Related]
51. The effect of low estrogen state on serotonin transporter function in mouse hippocampus: a behavioral and electrochemical study. Bertrand PP; Paranavitane UT; Chavez C; Gogos A; Jones M; van den Buuse M Brain Res; 2005 Dec; 1064(1-2):10-20. PubMed ID: 16298349 [TBL] [Abstract][Full Text] [Related]
52. Pharmacological and behavioral characterization of D-473, an orally active triple reuptake inhibitor targeting dopamine, serotonin and norepinephrine transporters. Dutta AK; Santra S; Sharma H; Voshavar C; Xu L; Mabrouk O; Antonio T; Reith ME PLoS One; 2014; 9(11):e113420. PubMed ID: 25427177 [TBL] [Abstract][Full Text] [Related]
53. [Mechanism of action of antidepressant drugs: importance of genetically modified mice in the pharmacological in vivo approach]. Gardier A Therapie; 2005; 60(5):469-76. PubMed ID: 16433012 [TBL] [Abstract][Full Text] [Related]
54. Expression and immunolocalization of the plasma membrane monoamine transporter in the brain. Dahlin A; Xia L; Kong W; Hevner R; Wang J Neuroscience; 2007 May; 146(3):1193-211. PubMed ID: 17408864 [TBL] [Abstract][Full Text] [Related]
55. Influence of brain-derived neurotrophic factor (BDNF) on serotonin neurotransmission in the hippocampus of adult rodents. Benmansour S; Deltheil T; Piotrowski J; Nicolas L; Reperant C; Gardier AM; Frazer A; David DJ Eur J Pharmacol; 2008 Jun; 587(1-3):90-8. PubMed ID: 18474368 [TBL] [Abstract][Full Text] [Related]
56. Serotonin transporter and receptor ligands with antidepressant activity as neuroprotective and proapoptotic agents. Chilmonczyk Z; Bojarski AJ; Pilc A; Sylte I Pharmacol Rep; 2017 Jun; 69(3):469-478. PubMed ID: 28324844 [TBL] [Abstract][Full Text] [Related]
57. Effects of serotonin in the hippocampus: how SSRIs and multimodal antidepressants might regulate pyramidal cell function. Dale E; Pehrson AL; Jeyarajah T; Li Y; Leiser SC; Smagin G; Olsen CK; Sanchez C CNS Spectr; 2016 Apr; 21(2):143-61. PubMed ID: 26346726 [TBL] [Abstract][Full Text] [Related]
58. Revisiting serotonin reuptake inhibitors and the therapeutic potential of "uptake-2" in psychiatric disorders. Daws LC; Koek W; Mitchell NC ACS Chem Neurosci; 2013 Jan; 4(1):16-21. PubMed ID: 23336039 [TBL] [Abstract][Full Text] [Related]
59. Integrating the monoamine, neurotrophin and cytokine hypotheses of depression--a central role for the serotonin transporter? Haase J; Brown E Pharmacol Ther; 2015 Mar; 147():1-11. PubMed ID: 25444754 [TBL] [Abstract][Full Text] [Related]
60. Monoamine transporter gene polymorphisms and antidepressant response in koreans with late-life depression. Kim H; Lim SW; Kim S; Kim JW; Chang YH; Carroll BJ; Kim DK JAMA; 2006 Oct; 296(13):1609-18. PubMed ID: 17018806 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]